tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Cyclopharm Responds to ASX Inquiry on Share Trading Surge
Company AnnouncementsCyclopharm Responds to ASX Inquiry on Share Trading Surge
13d ago
CYC
Cyclopharm Expands Technegas Footprint in U.S. Market
PremiumCompany Announcements
Cyclopharm Expands Technegas Footprint in U.S. Market
1M ago
CYC
Cyclopharm: Technegas Poised for US Market Breakthrough
PremiumCompany Announcements
Cyclopharm: Technegas Poised for US Market Breakthrough
1M ago
CYC
Cyclopharm’s Technegas Advances Pulmonary Embolism Diagnostics
PremiumCompany Announcements
Cyclopharm’s Technegas Advances Pulmonary Embolism Diagnostics
2M ago
CYC
Cyclopharm Secures Key Orders from US VA Hospitals
PremiumCompany Announcements
Cyclopharm Secures Key Orders from US VA Hospitals
2M ago
CYC
Cyclopharm Limited Shares Future Financial Outlook
PremiumCompany AnnouncementsCyclopharm Limited Shares Future Financial Outlook
2M ago
CYC
Cyclopharm Secures Deal with US Veterans Administration
Premium
Company Announcements
Cyclopharm Secures Deal with US Veterans Administration
4M ago
CYC
Cyclopharm Director’s Shareholding Surges
Premium
Company Announcements
Cyclopharm Director’s Shareholding Surges
4M ago
CYC
Cyclopharm Limited Reports H1 Financials and US Growth
PremiumCompany Announcements
Cyclopharm Limited Reports H1 Financials and US Growth
5M ago
CYC
Cyclopharm’s US Expansion Boosts Growth Prospects
PremiumCompany Announcements
Cyclopharm’s US Expansion Boosts Growth Prospects
5M ago
CYC
Cyclopharm Limited Announces New Share Quotation
PremiumCompany Announcements
Cyclopharm Limited Announces New Share Quotation
7M ago
CYC
Cyclopharm Limited Announces New Share Issue
PremiumCompany Announcements
Cyclopharm Limited Announces New Share Issue
7M ago
CYC
Cyclopharm Director’s Shareholding Boosted
PremiumCompany AnnouncementsCyclopharm Director’s Shareholding Boosted
7M ago
CYC
Cyclopharm Director Buys Shares, Expands Holding
Premium
Company Announcements
Cyclopharm Director Buys Shares, Expands Holding
7M ago
CYC
Cyclopharm Limited Gears Up for ASX Expansion
Premium
Company Announcements
Cyclopharm Limited Gears Up for ASX Expansion
7M ago
CYC
Cyclopharm Corrects Share Issue Figures
PremiumCompany Announcements
Cyclopharm Corrects Share Issue Figures
7M ago
CYC
Cyclopharm Limited’s Share Plan Oversubscribed
PremiumCompany Announcements
Cyclopharm Limited’s Share Plan Oversubscribed
7M ago
CYC
Cyclopharm Doubles SPP Target, Secures $4M
PremiumCompany Announcements
Cyclopharm Doubles SPP Target, Secures $4M
7M ago
CYC
Cyclopharm’s Technegas Secures Key US Reimbursement Status
PremiumCompany Announcements
Cyclopharm’s Technegas Secures Key US Reimbursement Status
7M ago
CYC
Cyclopharm Shareholder Voting Power Shifts
PremiumCompany AnnouncementsCyclopharm Shareholder Voting Power Shifts
7M ago
CYC
Cyclopharm’s Major Shareholder Sees Reduced Voting Power
Premium
Company Announcements
Cyclopharm’s Major Shareholder Sees Reduced Voting Power
8M ago
CYC
Cyclopharm’s Technegas Gains CMS Reimbursement Status
Premium
Company Announcements
Cyclopharm’s Technegas Gains CMS Reimbursement Status
8M ago
CYC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >